As of 2025-09-18, the Relative Valuation of Myriad Genetics Inc (MYGN) is (52.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.40 USD, the upside of Myriad Genetics Inc based on Relative Valuation is -811.9%.
The range of the Relative Valuation is (48.36) - (66.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 15.7x | 10.8x |
| Forward P/E multiples | 11.4x - 16.2x | 14.0x |
| Fair Price | (48.36) - (66.84) | (52.68) |
| Upside | -753.6% - -1003.2% | -811.9% |
| Date | P/E |
| 2025-09-17 | -1.74 |
| 2025-09-16 | -1.76 |
| 2025-09-15 | -1.72 |
| 2025-09-12 | -1.70 |
| 2025-09-11 | -1.80 |
| 2025-09-10 | -1.62 |
| 2025-09-09 | -1.64 |
| 2025-09-08 | -1.62 |
| 2025-09-05 | -1.55 |
| 2025-09-04 | -1.59 |
| 2025-09-03 | -1.60 |
| 2025-09-02 | -1.62 |
| 2025-08-29 | -1.50 |
| 2025-08-28 | -1.46 |
| 2025-08-27 | -1.39 |
| 2025-08-26 | -1.36 |
| 2025-08-25 | -1.38 |
| 2025-08-22 | -1.41 |
| 2025-08-21 | -1.37 |
| 2025-08-20 | -1.30 |
| 2025-08-19 | -1.29 |
| 2025-08-18 | -1.34 |
| 2025-08-15 | -1.34 |
| 2025-08-14 | -1.38 |
| 2025-08-13 | -1.38 |
| 2025-08-12 | -1.42 |
| 2025-08-11 | -1.45 |
| 2025-08-08 | -1.48 |
| 2025-08-07 | -1.43 |
| 2025-08-06 | -1.33 |
| 2025-08-05 | -0.91 |
| 2025-08-04 | -0.93 |
| 2025-08-01 | -0.92 |
| 2025-07-31 | -0.90 |
| 2025-07-30 | -0.95 |
| 2025-07-29 | -0.96 |
| 2025-07-28 | -1.03 |
| 2025-07-25 | -1.05 |
| 2025-07-24 | -1.09 |
| 2025-07-23 | -1.11 |
| 2025-07-22 | -1.08 |
| 2025-07-21 | -1.05 |
| 2025-07-18 | -1.05 |
| 2025-07-17 | -1.13 |
| 2025-07-16 | -1.19 |
| 2025-07-15 | -1.17 |
| 2025-07-14 | -1.23 |
| 2025-07-11 | -1.25 |
| 2025-07-10 | -1.29 |
| 2025-07-09 | -1.34 |